Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MinTong Han Wei San (also known as Gan Wei Neng) is a traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Min Tong Pharmaceutical in Taiwan. It is produced as concentrated herbal granules using a low-heat drying process to maintain the chemical integrity of the constituent herbs, resulting in a 5:1 potency ratio. While the specific herbal composition and molecular mechanism of action are not publicly detailed in standard pharmaceutical databases, the product is marketed as an oral treatment following traditional Chinese medicinal principles, typically associated with gastrointestinal health. It is available as an over-the-counter (OTC) product in Taiwan.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MinTong Han Wei San.